Patents Examined by Miriam Sohn
  • Patent number: 4885264
    Abstract: Pressure-sintered polycrystalline mixed materials, with a base of boron nitride, oxides and carbides, are provided in which the hexagonal boron nitride fraction is about 30 to about 85% by weight, the oxide fraction (ZrO.sub.2, MgO) is about 10 to about 50% by weight, and the carbide fraction (SiC, TiC, ZrC) is about 5 to about 20% by weight. These mixed materials have a density of at least 94% of the theoretical density and can be produced by hot-pressing powder mixtures composed of hexagonal boron nitride, the selected oxides and carbides at temperatures in the range of from 1500.degree. C. to 1800.degree. C. under a die pressure of 7 to 20 MPa or by isostatically hot-pressing, in a vacuum tight closed case, at temperatures in the range from about 1400.degree. C. to about 1700.degree. C. under a pressure of about 100 to about 300 MPa in a high-pressure autoclave using an inert gas as the pressure transfer medium.
    Type: Grant
    Filed: April 28, 1989
    Date of Patent: December 5, 1989
    Assignee: Elektroschmelzwerk Kempten GmbH
    Inventors: Peter Sindlhauser, Klaus Hunold, Alfred Lipp
  • Patent number: 4877776
    Abstract: A K-252 compound represented by the formula: ##STR1## wherein R.sup.1 and R.sup.2 are independently H or OH; X represents COOH, COOR or CH.sub.2 OH; Y represents H, R or COR; and Z represents OH, OR or SR, wherein R represents lower alkyl has C-kinase inhibitory activity and is expected to be useful as an active ingredient of anti-tumor agents, etc.
    Type: Grant
    Filed: December 22, 1988
    Date of Patent: October 31, 1989
    Assignee: Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Chikara Murakata, Akira Sato, Masaji Kasai, Eiji Kobayashi, Makoto Morimoto, Shiro Akinaga
  • Patent number: 4876339
    Abstract: A reaction medium of ethanol condensed with 1-20, most preferably 4-6 moles, of ethylene or propylene oxide per mole of ethanol greatly improves the practicality of the preparation of azacycloalkane-2,2-diphosphonic acids of the general formula I: ##STR1## where R means a hydrogen or a lower alkyl radical with from 1 to 3 carbon atoms, and n means an integer between 3 and 11, by phosphonylating the corresponding lactams with phosphonic acid and phosphorous trihalides in the presence of water.
    Type: Grant
    Filed: March 10, 1989
    Date of Patent: October 24, 1989
    Assignee: Henkel Kommanditgesellschaft auf Aktien
    Inventors: Helmut Blum, Siglinde Hemmann
  • Patent number: 4866056
    Abstract: A compound of formula (I): ##STR1## in which R is optionally substituted phenyl; C.sub.3-8 cycloalkyl; C.sub.5-8 cycloalkenyl; C.sub.1-8 alkyl which may be straight or branched; C.sub.2-8 alkenyl which may be straight or branched; 5- or 6-membered heterocyclyl; or optionally substituted phenyl C.sub.1-4 alkyl, each of Y and Z, which may be the same or different, is oxygen or sulphur; and X is --CH.sub.2 -- or oxygen, a process for the preparation of such compounds and their use in human and veterinary medicine.
    Type: Grant
    Filed: September 17, 1986
    Date of Patent: September 12, 1989
    Assignee: Beecham Group, p.l.c.
    Inventors: Roderick J. Dorgan, Richard L. Elliott
  • Patent number: 4841046
    Abstract: The present invention refers to an improved method for the preparation of 6,11-dihydro-5H-pyrido[2,3-b][1,5]benzodiazepin-5-one in which the condensation between 2-chloronicotinic acid and o-phenylenediamine is carried out by refluxing in the presence of a solvent consisting of a cycloalkanol. The end product is in pure state and it may be utilized as such.
    Type: Grant
    Filed: October 26, 1988
    Date of Patent: June 20, 1989
    Assignee: Dompe' Farmaceutici S.p.A.
    Inventors: Roberto P. Giani, Ettore Parini, Giancarlo Tonon, Massimiliano Borsa
  • Patent number: 4841063
    Abstract: This disclosure relates to a novel class of 2-alkyl-3-haloisothiazolium salts. These salts have been found to be useful in controlling the growth of bacteria and fungi. They have also been found to be useful intermediates in the preparation of novel and known antibacterial and antifungal compounds.
    Type: Grant
    Filed: January 31, 1984
    Date of Patent: June 20, 1989
    Assignee: Givaudan Corporation
    Inventors: Joseph A. Virgilio, Milton Manowitz, Emanuel Heilweil
  • Patent number: 4833244
    Abstract: Novel ethanobenzazepines, processes for the preparation thereof, and a method of alleviating pain utilizing compounds or compositions thereof are disclosed.
    Type: Grant
    Filed: October 1, 1987
    Date of Patent: May 23, 1989
    Assignee: Hoechst-Rouseel Pharmaceuticals Inc.
    Inventors: Raymond W. Kosley, Jr., Bernhard Seuring
  • Patent number: 4826840
    Abstract: An indene compound of the general formula (I): ##STR1## in which R.sub.1 represents a lower alkyl group, R.sub.2 represents a hydrogen atom, an aryl group or lower alkyl group, R.sub.3 represents an alkyl group, and n indicates an integer of 2 or 3; or a salt thereof. The compound has very strong ameliorating or improving effects on cerebral circulation and metabolism, and thus is very useful for ameliorating, or suppressing the progress of, disturbances of brain tissues and functions.
    Type: Grant
    Filed: June 19, 1987
    Date of Patent: May 2, 1989
    Assignee: Taiyo Pharmaceutical Industry Co., Ltd.
    Inventors: Shozo Nakaoku, Eiji Imai, Yasuhiro Oshika, Kazuo Ohira
  • Patent number: 4820818
    Abstract: The muscle relaxant (E)-3-(9-chloro-5,6-dihydro-11H-pyrrolo[2,1-b][3]benzazepin-11-ylidene-N,N -dimethyl-1-propanamine is prepared by the geometric stereoselective dehydration of the intermediate carbinol with acidic agents and organic bases and low temperatures.
    Type: Grant
    Filed: May 2, 1988
    Date of Patent: April 11, 1989
    Assignee: Merck & Co., Inc.
    Inventors: Ruth V. Wattley, Gerard R. Kieczykowski